Tag: Citis
Browse our exclusive articles!
Sun Pharma added to Citi’s pan-Asia focus list with 35% upside
Shares of Sun Pharmaceutical Industries Ltd., India's largest drugmaker, will be on investors' radar after global brokerage firm Citi reiterated its 'Buy' rating and...
Gold could reach $3,600 as global demand peaks, says Citi’s Max Layton
Gold and silver continue their stellar run, with prices reaching record highs in both global and Indian markets, driven by investor optimism over potential...
Take profits in India, look to re-enter on better value: Citi’s Drew Pettit
India may still be a strong structural story, but equity valuations leave little room for upside in the near term, according to Drew Pettit,...
Markets may be underpricing tariff risks, earnings could take a hit: Citi’s Drew Pettit
Markets may be underestimating tariff risks, which could lead to earnings downgrades if they persist, according to Drew Pettit, Director-US Equity Strategy at Citi.While...
